Tower Research Capital LLC (Trc) Glycomimetics Inc Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Glycomimetics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 19,559 shares of GLYC stock, worth $5,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,559

Holding current value

$5,672

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.14 - $0.54 $2,738 - $10,561	19,559 New	19,559 $4,000
Q1 2024 May 15, 2024	BUY	$2.55 - $3.49 $52,886 - $72,382	20,740 Added 719.64%	23,622 $70,000
Q4 2023 Feb 13, 2024	SELL	$1.13 - $2.54 $2,011 - $4,521	-1,780 Reduced 38.18%	2,882 $6,000
Q3 2023 Nov 14, 2023	SELL	$1.29 - $1.73 $5,101 - $6,842	-3,955 Reduced 45.9%	4,662 $6,000
Q2 2023 Aug 14, 2023	SELL	$1.21 - $2.08 $19,147 - $32,913	-15,824 Reduced 64.74%	8,617 $14,000
Q1 2023 May 09, 2023	BUY	$1.25 - $4.05 $30,551 - $98,986	24,441 New	24,441 $30,000
Q3 2022 Nov 10, 2022	BUY	$0.55 - $0.9 $6,601 - $10,802	12,003 Added 125.37%	21,577 $12,000
Q2 2022 Aug 15, 2022	BUY	$0.54 - $1.15 $4,094 - $8,719	7,582 Added 380.62%	9,574 $6,000
Q1 2022 May 12, 2022	SELL	$1.0 - $1.58 $5,280 - $8,342	-5,280 Reduced 72.61%	1,992 $2,000
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.14 $3,191 - $4,742	2,216 Added 43.83%	7,272 $10,000
Q3 2021 Nov 15, 2021	SELL	$1.8 - $2.39 $19,310 - $25,639	-10,728 Reduced 67.97%	5,056 $11,000
Q2 2021 Aug 16, 2021	BUY	$2.16 - $3.18 $14,748 - $21,713	6,828 Added 76.24%	15,784 $36,000
Q1 2021 May 17, 2021	BUY	$2.89 - $4.22 $12,886 - $18,816	4,459 Added 99.15%	8,956 $27,000
Q4 2020 Feb 16, 2021	SELL	$2.69 - $4.24 $97,246 - $153,280	-36,151 Reduced 88.94%	4,497 $16,000
Q3 2020 Nov 16, 2020	BUY	$3.07 - $5.0 $102,172 - $166,405	33,281 Added 451.76%	40,648 $125,000
Q2 2020 Aug 13, 2020	BUY	$2.06 - $3.76 $15,176 - $27,699	7,367 New	7,367 $27,000
Q1 2020 May 15, 2020	SELL	$1.83 - $5.41 $21,544 - $63,691	-11,773 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$4.03 - $6.5 $8,978 - $14,482	-2,228 Reduced 15.91%	11,773 $62,000
Q3 2019 Nov 05, 2019	BUY	$2.8 - $12.85 $38,696 - $177,587	13,820 Added 7635.36%	14,001 $61,000
Q2 2019 Aug 13, 2019	SELL	$10.6 - $13.12 $13,260 - $16,413	-1,251 Reduced 87.36%	181 $2,000
Q1 2019 May 14, 2019	BUY	$9.96 - $13.44 $14,262 - $19,246	1,432 New	1,432 $18,000
Q4 2018 Feb 14, 2019	SELL	$8.47 - $14.71 $14,288 - $24,815	-1,687 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$13.7 - $17.12 $23,111 - $28,881	1,687 New	1,687 $24,000
Q2 2018 Aug 15, 2018	SELL	$14.63 - $19.19 $110,061 - $144,366	-7,523 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$16.06 - $25.35 $116,627 - $184,091	7,262 Added 2782.38%	7,523 $122,000
Q4 2017 Feb 09, 2018	BUY	$10.51 - $17.22 $2,743 - $4,494	261	261 $4,000

Others Institutions Holding GLYC

# of Institutions

Shares Held

30.3M

Call Options Held

51K

Put Options Held

1.4K

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $15.2M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Glycomimetics Inc Transaction History